Relationship between
BRCA1
MUTYH
OGG1
base excision repair
breast cancer
gene expression
mutation
ovarian cancer
oxidative stress
prevention
Journal
Molecular and clinical oncology
ISSN: 2049-9450
Titre abrégé: Mol Clin Oncol
Pays: England
ID NLM: 101613422
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
14
02
2020
accepted:
29
09
2020
entrez:
21
12
2020
pubmed:
22
12
2020
medline:
22
12
2020
Statut:
ppublish
Résumé
The aetiology of breast and ovarian cancer (BC/OC) is multi-factorial. At present, the involvement of base excision repair (BER) glycosylases (MUTYH and OGG1) in BC/OC predisposition is controversial. The present study investigated whether germline mutation status and mRNA expression of two BER genes,
Identifiants
pubmed: 33343895
doi: 10.3892/mco.2020.2177
pii: MCO-0-0-02177
pmc: PMC7725208
doi:
Types de publication
Journal Article
Langues
eng
Pagination
15Informations de copyright
Copyright: © Moscatello et al.
Références
FEBS Lett. 2009 May 6;583(9):1535-43
pubmed: 19364506
Oncotarget. 2018 Jan 2;9(22):16220-16233
pubmed: 29662639
N Engl J Med. 2003 Feb 27;348(9):791-9
pubmed: 12606733
Cancers (Basel). 2014 Apr 03;6(2):771-95
pubmed: 24704793
Breast Cancer Res Treat. 2012 Jul;134(1):219-27
pubmed: 22297469
J Biol Chem. 2011 Dec 30;286(52):44679-90
pubmed: 22057269
Nucleic Acids Res. 2019 Sep 26;47(17):9132-9143
pubmed: 31329989
Annu Rev Public Health. 2018 Apr 1;39:113-133
pubmed: 29328875
Gynecol Oncol. 2017 Jun;145(3):595-602
pubmed: 28237618
Mutagenesis. 2012 Jul;27(4):501-10
pubmed: 22451681
Cancer Res. 2000 Oct 1;60(19):5548-52
pubmed: 11034101
Nucleic Acids Res. 2014 Jan;42(Database issue):D980-5
pubmed: 24234437
J Med Genet. 2005 Sep;42(9):e54
pubmed: 16140997
Front Genet. 2013 Feb 28;4:18
pubmed: 23450852
Int J Cancer. 2006 Dec 1;119(11):2592-6
pubmed: 16929514
Oncotarget. 2017 Jul 20;8(47):81803-81812
pubmed: 29137223
JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
Cell Cycle. 2010 Jul 1;9(13):2471-2
pubmed: 20581465
Cancer. 2012 Apr 15;118(8):1989-93
pubmed: 21952991
Biomed Res Int. 2020 Mar 16;2020:1726309
pubmed: 32258104
Nucleic Acids Res. 2016 Jan 4;44(D1):D862-8
pubmed: 26582918
Breast Cancer Res Treat. 2009 Apr;114(3):575-8
pubmed: 18454351
Biol Chem. 2014 Feb;395(2):203-30
pubmed: 24127541
Bioinformatics. 2017 Jul 15;33(14):i389-i398
pubmed: 28882004
Cancer. 1993 May 15;71(10):3036-43
pubmed: 8387875
Hum Mutat. 2003 Aug;22(2):178-9
pubmed: 12872265
Clin Cancer Res. 2011 Apr 1;17(7):1701-12
pubmed: 21355073
Proc Natl Acad Sci U S A. 1999 Oct 26;96(22):12384-8
pubmed: 10535931
Crit Rev Oncol Hematol. 2011 Dec;80(3):347-68
pubmed: 21288735
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
Science. 2018 Nov 16;362(6416):834-839
pubmed: 30442810
Breast Cancer Res. 2007;9(2):104
pubmed: 17466083
Mol Carcinog. 2001 Aug;31(4):214-23
pubmed: 11536371
BMC Cancer. 2013 May 22;13:253
pubmed: 23697596
Carcinogenesis. 1994 Nov;15(11):2637-43
pubmed: 7955118
Carcinogenesis. 2009 Jan;30(1):2-10
pubmed: 18978338
Nature. 2002 Dec 19-26;420(6917):860-7
pubmed: 12490959
J Exp Clin Cancer Res. 2015 Oct 28;34:131
pubmed: 26511139
Eur J Cancer. 2011 May;47(7):1046-55
pubmed: 21195604
Dis Markers. 2015;2015:690878
pubmed: 26089588
Adv Cancer Res. 2013;119:107-25
pubmed: 23870510
Oncotarget. 2015 Aug 14;6(23):19671-84
pubmed: 26109431
Acc Chem Res. 2014 Apr 15;47(4):1238-46
pubmed: 24646203
Mol Cell Biol. 1999 Dec;19(12):8292-301
pubmed: 10567554
DNA Repair (Amst). 2018 Jan;61:56-62
pubmed: 29207315
EMBO J. 2008 Jan 23;27(2):421-32
pubmed: 18188152
Ann Oncol. 2007 Jun;18 Suppl 6:vi86-92
pubmed: 17591842